SCHEMBL12440417

SCHEMBL12440417

Clc1ccc(-c2ccc(Cn3ccc4cc(CN5CCCC5)ccc43)nc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MCHR1 Q99705 9/20 0.42
HRH3 Q9Y5N1 2/20 0.42
HTR2C P28335 1/20 0.42
CHEK1 O14757 2/20 0.42
HRH4 Q9H3N8 1/20 0.42
HTR6 P50406 2/20 0.41
LSS P48449 1/20 0.41
KCNH2 Q12809 1/20 0.41
CHRM1 P11229 2/20 0.41
HTR2A P28223 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4508922 0.82 MCHR1 (0.50) NPC1RAB9AKDM4EALDH1A1MCHR1
SCHEMBL12440536 0.77 KDM4E (0.55) KDM4EALDH1A1MCHR1HRH3CHEK1
SCHEMBL12441452 0.76 KDM4E (0.58) KDM4EALDH1A1MCHR1HRH3CHEK1
SCHEMBL12440591 0.75 MCHR1 (0.52) NPC1RAB9AKDM4EALDH1A1MCHR1
SCHEMBL12440639 0.74 MCHR1 (0.48) MCHR1HTR6CHRM1HTR2A
SCHEMBL12440662 0.74 HRH3 (0.57) KDM4EALDH1A1MCHR1HRH3HRH4
SCHEMBL12440034 0.72 KDM4E (0.60) KDM4EALDH1A1MCHR1HRH3HTR2C
SCHEMBL12440303 0.71 NPC1 (0.47) NPC1RAB9AKDM4EALDH1A1MCHR1
SCHEMBL12440554 0.70 CHKA (0.47) KDM4EALDH1A1MCHR1HRH3HRH4
SCHEMBL2328668 0.70 MCHR1 (0.67) MCHR1CHRM1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558578-B1 NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM PHARMA (DE) 2013-03-13 EP disclosed
EP-2357173-A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-08-17 EP disclosed